UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 494

Sortiert nach

Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study

BMJ (Online), 2012-02, Vol.344 (7848), p.e977

International edition, 2012

Volltextzugriff (PDF)

Statins and congenital malformations: cohort study

BMJ (Online), 2015-03, Vol.350, p.h1035

2015

Volltextzugriff (PDF)

Patterns of cardiovascular risk in rheumatoid arthritis

Annals of the rheumatic diseases, 2006-12, Vol.65 (12), p.1608-1612

2006

Volltextzugriff (PDF)

Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges

Osteoporosis international, 2013-01, Vol.24 (1), p.237-244

2013

Volltextzugriff (PDF)

Defining "Innovativeness" in Drug Development: A Systematic Review

Clinical pharmacology and therapeutics, 2013-09, Vol.94 (3), p.336-348

2013

Volltextzugriff (PDF)

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

Circulation (New York, N.Y.), 2004-05, Vol.109 (17), p.2068-2073

2004

Volltextzugriff (PDF)

Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect

American journal of epidemiology, 2007-08, Vol.166 (3), p.348-354

2007

Volltextzugriff (PDF)

Uric acid lowering therapy: prescribing patterns in a large cohort of older adults

Annals of the rheumatic diseases, 2008-05, Vol.67 (5), p.609-613

2008

Volltextzugriff (PDF)

Refilling and Switching of Antiepileptic Drugs and Seizure-Related Events

Clinical pharmacology and therapeutics, 2010-09, Vol.88 (3), p.347-353

2010

Volltextzugriff (PDF)

FDA Standards — Good Enough for Government Work?

The New England journal of medicine, 2005-09, Vol.353 (10), p.969-972

Avorn, Jerry

2005

Volltextzugriff (PDF)

Drug Labels: A Flawed Source of Data for Studying Orphan Drug Approvals

Clinical pharmacology and therapeutics, 2012-12, Vol.92 (6), p.694-694

2012

Volltextzugriff (PDF)

Clinical and Regulatory Features of Drugs Not Initially Approved by the FDA

Clinical pharmacology and therapeutics, 2013-12, Vol.94 (6), p.670-677

2013

Volltextzugriff (PDF)

Trends in direct-to-consumer advertising for prescription contraceptives

Contraception (Stoneham), 2015-10, Vol.92 (4), p.390-390

2015

Volltextzugriff (PDF)

Improving drug use in elderly patients: getting to the next level

JAMA : the journal of the American Medical Association, 2001-12, Vol.286 (22), p.2866

Avorn, J

2001

Volltextzugriff (PDF)

Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics

Annals of internal medicine, 2000-07, Vol.133 (2), p.128

2000

Volltextzugriff (PDF)

Hazardous Benzodiazepine Regimens in the Elderly: Effects of Half-Life, Dosage, and Duration on Risk of Hip Fracture

The American journal of psychiatry, 2001-06, Vol.158 (6), p.892-898

2001

Volltextzugriff (PDF)

Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors

The New England journal of medicine, 2004-11, Vol.351 (21), p.2187-2194

2004

Volltextzugriff (PDF)

Are Risk Evaluation and Mitigation Strategies Associated With Less Off-Label Use of Medications? The Case of Immune Thrombocytopenia

Clinical pharmacology and therapeutics, 2015-02, Vol.97 (2), p.186-193

2015

Volltextzugriff (PDF)

Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review

Osteoporosis international, 2009-12, Vol.20 (12), p.2127-2134

2009

Volltextzugriff (PDF)

A review of uses of health care utilization databases for epidemiologic research on therapeutics

Journal of clinical epidemiology, 2005-04, Vol.58 (4), p.323-337

2005

Volltextzugriff (PDF)

The Hepatotoxicity of Antifungal Medications in Bone Marrow Transplant Recipients

Clinical infectious diseases, 2005-08, Vol.41 (3), p.301-307

2005

Volltextzugriff (PDF)

Quality indicators for appropriate medication use in vulnerable elders

Annals of internal medicine, 2001-10, Vol.135 (8 Pt 2), p.703

2001

Volltextzugriff (PDF)

Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution—A Simulation Study

American journal of epidemiology, 2010-10, Vol.172 (7), p.843-854

2010

Volltextzugriff (PDF)

1703P Value of molecular targets and genome-targeted cancer therapies FDA-approved, 2015-2022

Annals of oncology, 2023-10, Vol.34, p.S930-S930

2023

Volltextzugriff (PDF)

The FDA Amendments Act of 2007 — Assessing Its Effects a Decade Later

The New England journal of medicine, 2018-09, Vol.379 (12), p.1097-1099

2018

Volltextzugriff (PDF)

1 – 25 von 494

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(438)
Mit Volltextzugriff
(332)

Publikationsform

Sprache

Englisch
(494)
Japanisch
(62)

Erscheinungsjahr

n.n

Thema

Humans
(377)
Science & Technology
(361)
Life Sciences & Biomedicine
(357)
Aged
(219)
Biological And Medical Sciences
(206)
Medical Sciences
(205)
Female
(197)
Male
(186)
United States
(125)
General & Internal Medicine
(115)
Medicine, General & Internal
(113)
Aged, 80 And Over
(106)
Middle Aged
(95)
Pharmacology. Drug Treatments
(84)
Public, Environmental & Occupational Health
(80)
Adult
(67)
Health Care Sciences & Services
(63)
Prescription Drugs
(60)
Risk Factors
(59)
Epidemiology
(57)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study

Statins and congenital malformations: cohort study

Patterns of cardiovascular risk in rheumatoid arthritis

Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges

Defining "Innovativeness" in Drug Development: A Systematic Review

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect

Uric acid lowering therapy: prescribing patterns in a large cohort of older adults

Refilling and Switching of Antiepileptic Drugs and Seizure-Related Events

FDA Standards — Good Enough for Government Work?

Drug Labels: A Flawed Source of Data for Studying Orphan Drug Approvals

Clinical and Regulatory Features of Drugs Not Initially Approved by the FDA

Trends in direct-to-consumer advertising for prescription contraceptives

Improving drug use in elderly patients: getting to the next level

Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics

Hazardous Benzodiazepine Regimens in the Elderly: Effects of Half-Life, Dosage, and Duration on Risk of Hip Fracture

Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors

Are Risk Evaluation and Mitigation Strategies Associated With Less Off-Label Use of Medications? The Case of Immune Thrombocytopenia

Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review

A review of uses of health care utilization databases for epidemiologic research on therapeutics

The Hepatotoxicity of Antifungal Medications in Bone Marrow Transplant Recipients

Quality indicators for appropriate medication use in vulnerable elders

Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution—A Simulation Study

1703P Value of molecular targets and genome-targeted cancer therapies FDA-approved, 2015-2022

The FDA Amendments Act of 2007 — Assessing Its Effects a Decade Later

Suchergebnisse filtern